In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Human history was forever changed with the discovery of antibiotics in 1928. Infectious diseases such as pneumonia, tuberculosis and sepsis were widespread and lethal until antibiotics made them ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until ...

The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...

Identifying the mechanisms of action driving a drug’s anti-cancer efficacy is critical for identifying optimal biomarkers, indications, and combinations for clinical success. Yet, systematically ...

Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and ...

Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...

President Donald Trump's steadfast resolve to protect the American people from dangerous drugs deserves praise. His ...